Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Other Working Capital Changes: 2009-2024

Historic Other Working Capital Changes for Fortress Biotech (FBIO) over the last 16 years, with Dec 2024 value amounting to -$968,000.

  • Fortress Biotech's Other Working Capital Changes rose 15.59% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 million, marking a year-over-year decrease of 818.52%. This contributed to the annual value of -$968,000 for FY2024, which is 4078.14% down from last year.
  • Latest data reveals that Fortress Biotech reported Other Working Capital Changes of -$968,000 as of FY2024, which was down 4,078.14% from $24,333 recorded in FY2023.
  • Over the past 5 years, Fortress Biotech's Other Working Capital Changes peaked at $2.6 million during FY2021, and registered a low of -$968,000 during FY2024.
  • Its 3-year average for Other Working Capital Changes is -$191,222, with a median of $24,333 in 2023.
  • In the last 5 years, Fortress Biotech's Other Working Capital Changes spiked by 244.05% in 2020 and then plummeted by 4,078.14% in 2024.
  • Yearly analysis of 5 years shows Fortress Biotech's Other Working Capital Changes stood at $2.6 million in 2020, then rose by 0.81% to $2.6 million in 2021, then slumped by 85.83% to $370,000 in 2022, then plummeted by 93.42% to $24,333 in 2023, then tumbled by 4,078.14% to -$968,000 in 2024.